Two highly regarded Vanderbilt University Medical Center (VUMC) infectious disease clinicians were recognized with service awards from prominent organizations during IDWeek in San Diego, California, Oct. 4-8.

Clinical and translational research at Vanderbilt University Medical Center (VUMC) is thriving.

Dan Roden, M.D., Senior Vice President for Personalized Medicine at Vanderbilt University Medical Center (VUMC), was named to receive the 2017 Medicine Alumni Global Lifetime Achievement Award by the Faculty of Medicine of his alma mater, McGill University.

Members of the Vanderbilt University Medical Center (VUMC) community and others whose lives and careers have been influenced by legendary cancer investigator, educator and administrator Harold (Hal) Moses, M.D., have endowed the Linda and Harold L. Moses, M.D. Career Development Fund.

Germ-killing robots are being enlisted to further safeguard Vanderbilt University Medical Center (VUMC) patients from health care-associated infections.

Calcium intake appears to protect against colorectal cancer in individuals with certain gene variants, Vanderbilt researchers have discovered.

Vanderbilt investigators have discovered a novel non-genetic cause of resistance to the targeted anti-cancer therapy cetuximab. Their findings, reported this week in Nature Medicine, suggest a strategy for overcoming this resistance.